You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myocardial Perfusion

Showing 1 - 25 of 7,626
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dotarem Evaluation for Myocardial Perfusion CMR

Recruiting
  • Myocardial Perfusion Imaging
  • Magnetic Resonance Imaging
  • Gadavist 15Ml Solution for Injection
  • Charleston, South Carolina
    Medical University of South Carolina
Jan 23, 2023

Sickle Cell Disease Trial in Memphis ([13N]NH3, Lexiscan, Positron emission tomography)

Not yet recruiting
  • Sickle Cell Disease
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jan 11, 2023

Myocardial Infarction Trial in Nantes (Dynamic 99mTc-Tetrofosmin CZT-SPECT)

Not yet recruiting
  • Myocardial Infarction
  • Dynamic 99mTc-Tetrofosmin CZT-SPECT
  • Nantes, France
    Nantes University Hospital
Jul 3, 2023

Myocardial Ischemia, Myocardial Infarction, Autonomic Dysfunction Trial in Tilburg (Care as usual with information support, Care

Recruiting
  • Myocardial Ischemia
  • +2 more
  • Care as usual with information support
  • +2 more
  • Tilburg, Noord-Brabant, Netherlands
    Institute Verbeeten
May 31, 2023

Sonazoid in Myocardial Perfusion Imaging

Not yet recruiting
  • Diagnostic Imaging
  • Myocardial Ischemia
  • Contrast Stress Echocardiography
  • Harrow, Middx, United Kingdom
    London North West University Healthcare NHS Trust
Nov 24, 2022

Chronic Inflammation on Myocardial Perfusion and Function

Completed
  • Psoriasis
  • 13N Amonia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 24, 2023

Myocardial Perfusion Imaging by Combined 15O-H2O PET and MR

Completed
  • Ischemic Heart Disease
    • Aarhus, Aarhus N, Denmark
      Aarhus University Hospital
    Dec 21, 2022

    Single Rest-Stress Imaging Protocol for Myocardial Perfusion

    Recruiting
    • Coronary Artery Disease
    • Myocardial Ischemia
    • Single-Scan Two-Injection Protocol
    • Boston, Massachusetts
      Massachusetts General Hospital
    Nov 15, 2022

    Treatment Decision, Coronary Artery Disease Trial in Beijing, Zhengzhou, Changchun (Invasive coronary angiography, routine

    Recruiting
    • Treatment Decision, Coronary Artery Disease
    • Invasive coronary angiography
    • routine medical treatment
    • Beijing, Beijing, China
    • +3 more
    Oct 31, 2023

    Coronary Artery Disease, Ischemia Trial in Baltimore (Computed Tomography Angiography)

    Active, not recruiting
    • Coronary Artery Disease
    • Ischemia
    • Computed Tomography Angiography
    • Baltimore, Maryland
      Johns Hopkins Unversity School of Medicine
    Jan 18, 2023

    The CZT Dynamic Myocardial Perfusion Imaging

    Completed
    • Cardiac Disease
    • thallium-201
    • New Taipei City, Taiwan
      Far Eastern Memorial Hospital
    Oct 20, 2022

    'Prognostic Value of Hyperpolarized 13C MRI for Clinical

    Not yet recruiting
    • Ventricular Function, Left
    • Myocardial Perfusion Imaging
      • (no location specified)
      Sep 13, 2023

      Coronary Artery Disease, Prediabetic State Trial in Seoul (Dapagliflozin 10mg, Lifestyle modification)

      Terminated
      • Coronary Artery Disease
      • Prediabetic State
      • Dapagliflozin 10mg
      • Lifestyle modification
      • Seoul, Korea, Republic of
        Asan Medical Center
      Sep 21, 2022

      Coronary Artery Disease Trial in Saint Louis (Ga-68 Galmydar, 13N-ammonia)

      Recruiting
      • Coronary Artery Disease
      • Saint Louis, Missouri
        Washington University School of Medicine
      Nov 20, 2022

      Coronary Artery Disease Trial in Atlanta (PET-MPI Protocol, CT-MPI, CT-FFR)

      Recruiting
      • Coronary Artery Disease
      • PET-MPI Protocol
      • +3 more
      • Atlanta, Georgia
        Emory University Hospital
      Jul 6, 2022

      Coronary Artery Disease, Myocardial Perfusion Abnormalities Trial in Rochester, Omaha (Regadenoson; Optison)

      Completed
      Has Results
      • Coronary Artery Disease
      • Myocardial Perfusion Abnormalities
      • Regadenoson; Optison
      • Rochester, Minnesota
      • +1 more
      Dec 6, 2022

      Hypertrophic Cardiomyopathy Trial in London (Asynchronous dual chamber pacing (DOO) with paced ventricular activation,

      Active, not recruiting
      • Hypertrophic Cardiomyopathy
      • Asynchronous dual chamber pacing (DOO) with paced ventricular activation
      • Asynchronous atrial pacing (AOO) with intrinsic ventricular activation
      • London, Thames, United Kingdom
        Barts Heart Centre
      Sep 30, 2022

      Cardiac Function Trial in Westminster (regadenoson)

      Completed
      Has Results
      • Cardiac Function
      • Westminster, Maryland
        University of MD Cardiology Physicians
      Jul 29, 2022

      Coronary Artery Disease Trial in Saint Louis (Ga-68 Galmydar)

      Completed
      • Coronary Artery Disease
      • Ga-68 Galmydar
      • Saint Louis, Missouri
        Washington University School of Medicine
      Oct 5, 2022

      Breathing Maneuvers for Inducible Myocardial Perfusion Deficits

      Recruiting
      • Coronary Artery Disease, Hyperventilation, Breath-hold, Pulse Rate
      • 4 minute breathing maneuver
      • Montréal, Quebec, Canada
        The Research Institute of the McGill University Health Center
      Aug 23, 2022

      Healthy Adults Trial in Rochester (Real-Time Myocardial Echocardiography (RTMPE), Magnetic resonance image (MRI))

      Completed
      • Healthy Adults
      • Real-Time Myocardial Echocardiography (RTMPE)
      • Magnetic resonance image (MRI)
      • Rochester, Minnesota
        Mayo clinic Rochester
      Apr 6, 2022

      Coronary Disease Trial in Zhengzhou (remote ischemic preconditioning (RIPC))

      Recruiting
      • Coronary Disease
      • remote ischemic preconditioning （RIPC）
      • Zhengzhou, Henan, China
        Fuwai central China cardiovascular Hospital
      Mar 29, 2022

      Coronary Artery Disease Trial in Basel (99mTc-sestamibi myocardial perfusion SPECT, 82Rb-Chloride myocardial perfusion PET with

      Recruiting
      • Coronary Artery Disease
      • 99mTc-sestamibi myocardial perfusion SPECT
      • 82Rb-Chloride myocardial perfusion PET with CCTA
      • Basel, Switzerland
        Clinic of Radiology & Nuclear Medicine, University Hospital of B
      Dec 7, 2021

      Coronary Artery Disease (CAD) Trial in Beijing (XTR004)

      Completed
      • Coronary Artery Disease (CAD)
      • Beijing, Beijing, China
      • +1 more
      May 23, 2023

      Serial PET MPI in Patients Undergoing Cancer Treatment

      Enrolling by invitation
      • Cancer
      • +3 more
        • Los Angeles, California
          West Los Angeles VA Medical Center
        Jun 12, 2023